Finasteride Cost in Missouri 2026

What Does Finasteride Actually Cost in Missouri in 2026?

Generic finasteride tablets are available at Missouri retail pharmacies for roughly $12 per month when you use a free discount card. That is a 86% reduction from Merck's brand-name Propecia list price of approximately $85 per month. The gap is significant, and most patients never need to pay the list price.

Finasteride is a type II 5-alpha-reductase inhibitor. It blocks the conversion of testosterone to dihydrotestosterone (DHT), the androgen responsible for miniaturizing hair follicles in androgenetic alopecia (AGA) and for driving prostate enlargement in benign prostatic hyperplasia (BPH). The FDA first approved finasteride 5 mg (Proscar) in 1992 for BPH and finasteride 1 mg (Propecia) in 1997 for male AGA. Generic versions entered the market after patent expiration and now dominate prescribing volume.

Pricing at Missouri pharmacies varies by chain and by whether you use a coupon. Representative 2026 retail cash prices:

• Walmart (30-day supply, 1 mg): $9 to $14 with GoodRx
• CVS: $10 to $18 with coupon
• Walgreens: $11 to $19 with coupon
• Independent compounding pharmacy (1 mg oral): $30 to $50

GoodRx coupons are accepted at more than 95% of U.S. retail pharmacies and consistently push generic finasteride below $15 per month in Missouri markets including Kansas City, St. Louis, Springfield, and Columbia.

The 5 mg tablet (BPH dosing) often costs only marginally more than the 1 mg tablet. Some patients and prescribers use pill-splitters to obtain 0.25 mg doses experimentally, though that practice is off-label and not endorsed by the FDA label.

Does Missouri Medicaid Cover Finasteride?

Missouri Medicaid (MO HealthNet) does not cover finasteride for androgenetic alopecia or male pattern hair loss. Coverage for BPH indications is possible under certain MO HealthNet formularies, but finasteride prescribed primarily for hair retention is classified as a cosmetic indication and is excluded from standard state formularies.

MO HealthNet's Preferred Drug List places alpha-reductase inhibitors under a restricted tier. Prescribers seeking BPH coverage must submit prior authorization. The Missouri Department of Social Services confirmed in its 2024 pharmacy bulletin that cosmetic indications remain non-covered regardless of comorbidities.

Patients on Missouri Medicaid who want finasteride for AGA have two realistic options. First, pay cash and use a discount card to reach that $12 per month figure. Second, obtain a telehealth prescription and fill through a direct-to-consumer pharmacy that offers manufacturer pricing. Neither requires Medicaid participation.

The Centers for Medicare and Medicaid Services (CMS) National Coverage Database confirms that Medicare Part D similarly excludes drugs used for cosmetic purposes under the statutory exclusion at 42 U.S.C. § 1395w-102(e)(2)(A). Missouri residents on Medicare Part D face the same cosmetic-exclusion logic.

Is Compounded Finasteride Legal in Missouri?

Compounded finasteride is legal in Missouri when prepared by a state-licensed 503A compounding pharmacy operating under physician prescription. It is not legal for a pharmacy to compound finasteride in bulk for office stock without a patient-specific prescription under 503A rules.

The FDA's guidance on compounding under Section 503A of the FD&C Act requires patient-specific prescriptions, licensed pharmacist oversight, and compliance with USP <795> standards for non-sterile preparations. Missouri follows federal 503A rules and additionally requires compounding pharmacies to hold a Missouri Board of Pharmacy license. The Missouri Board of Pharmacy maintains a searchable licensee database where consumers can verify a pharmacy's standing before ordering.

Compounded finasteride in Missouri typically comes as:

• Oral capsules (1 mg or custom doses)
• Topical solution (0.1% or 0.25% finasteride in minoxidil base)
• Topical gel formulations

The topical route is not FDA-approved for finasteride in any form. That means the systemic absorption profile, efficacy data, and adverse-event rates from compounded topical finasteride are not derived from the same trials that support oral finasteride's label. Patients choosing topical compounded products should discuss this distinction explicitly with their prescriber.

Pricing for compounded finasteride in Missouri averages $45 per month, though 503A pharmacies in the St. Louis and Kansas City metro areas may price it between $35 and $60 depending on formulation complexity.

Clinical Evidence Supporting Finasteride Use

Finasteride's efficacy for AGA is well documented. Kaufman et al. (1998) published a 2-year randomized controlled trial (N=523 men) in the Journal of the American Academy of Dermatology showing that finasteride 1 mg daily produced a statistically significant increase in hair count versus placebo at 24 months, with 66% of treated men showing increased or maintained hair count compared to 7% in the placebo group [P<0.001]. That trial remains a foundational reference for AGA pharmacotherapy.

The FDA-approved prescribing information for finasteride 1 mg (Propecia) states: "In men with male pattern hair loss, the 5-alpha reductase type II isoenzyme is responsible for conversion of testosterone to DHT in the hair follicle. Administration of finasteride decreased scalp DHT concentrations 64% in men with male pattern hair loss."

A 2019 systematic review in JAMA Dermatology (N=17 RCTs) found that oral finasteride 1 mg was significantly more effective than placebo for hair count increase, with a pooled standardized mean difference of 0.82 (95% CI 0.54 to 1.10). That review also noted that sexual adverse effects occurred in approximately 3.8% of treated men versus 2.1% in placebo groups, a difference that was statistically significant [P<0.05] but modest in absolute terms.

For BPH, the PLESS trial (N=3,040) demonstrated that finasteride 5 mg daily over 4 years reduced the risk of acute urinary retention by 57% and the need for BPH-related surgery by 55% compared to placebo. These outcomes inform the American Urological Association (AUA) BPH guideline, which endorses 5-alpha-reductase inhibitors for men with large prostates (>30 mL volume).

The Endocrine Society's clinical practice guideline on male hypogonadism does not include finasteride as a testosterone therapy, clarifying that its mechanism reduces DHT, not total testosterone, which matters for patients weighing finasteride against other androgenic therapies.

How Missouri Insurance Plans Handle Finasteride

Private insurance coverage for finasteride in Missouri depends heavily on indication and plan formulary. BPH indications carry stronger coverage rates than AGA.

For BPH (5 mg), most commercial plans in Missouri, including Anthem BlueCross BlueShield of Missouri, Cigna, and Aetna, list generic finasteride 5 mg on Tier 1 or Tier 2 with copays of $5 to $25 per month after the deductible. Prior authorization is rarely required for BPH because the indication is medical, not cosmetic.

For AGA (1 mg), the picture differs. Cosmetic exclusions in most Missouri commercial formularies mirror the Medicaid logic. The National Comprehensive Cancer Network (NCCN) and AUA guidelines do not list finasteride 1 mg as a medical necessity for any oncologic indication, which removes a pathway insurers sometimes use to authorize cosmetic-adjacent drugs. Patients have reported variable success obtaining AGA coverage by having a prescriber document psychosocial distress, though this is not a guaranteed path.

Employees of large Missouri employers (Boeing, Cerner/Oracle Health, Washington University health system) whose plans use custom pharmacy benefit managers may have more favorable formularies. Checking your specific plan's Summary of Benefits and Coverage (SBC) document is the only reliable way to know your actual tier and copay.

The Kaiser Family Foundation's 2024 Employer Health Benefits Survey found that 84% of covered workers in the U.S. are enrolled in plans with a 4-tier formulary structure, meaning generic finasteride almost always falls on Tier 1 when covered at all, keeping out-of-pocket costs low for qualifying indications.

Discount Programs and Savings Cards for Missouri Patients

Several programs reduce finasteride costs for Missouri patients who pay out of pocket.

GoodRx and similar platforms. Free to enroll, accepted at most Missouri pharmacies. GoodRx consistently shows finasteride 1 mg (30 tablets) at $9 to $15 across Missouri ZIP codes. GoodRx was studied in a 2021 JAMA Internal Medicine analysis showing it reduced drug spending by a mean of 52% versus cash price for common generics.

Merck Patient Assistance. Merck offers a patient assistance program for Propecia (brand) through the Merck Patient Assistance Program (Merck Helps). Eligibility is income-based and generally targets uninsured patients below 400% of the federal poverty level. Missouri residents can apply online. Because generic finasteride is so inexpensive ($12 per month), the Merck brand program is primarily useful for patients who specifically need Merck's formulation for documented generic-sensitivity reasons, a rare scenario.

Missouri Rx Plan (MoRx). The Missouri Rx Plan is a state-sponsored discount program for Missouri residents aged 65 and older or those with disabilities who are not enrolled in Medicare Part D. It negotiates drug discounts through the state's PBM. Finasteride is included in the MoRx formulary at discounted rates.

NeedyMeds. NeedyMeds lists Missouri-specific pharmaceutical assistance programs and can connect lower-income patients to manufacturer coupons or 340B-eligible community health centers in Missouri where finasteride may be dispensed at reduced cost.

Telehealth platform pricing. Several telehealth platforms operating in Missouri (including HealthRX) include finasteride as part of a monthly subscription that bundles the prescription, clinical visit, and pharmacy dispensing. These bundles typically land at $20 to $40 per month total, which is higher than a $12 coupon fill at Walmart but includes ongoing clinician oversight, DHT labs if ordered, and adverse-effect monitoring.

Telehealth Prescribing of Finasteride in Missouri

Missouri permits telehealth prescribing of finasteride under the Missouri Telehealth Act (RSMO § 191.1145). A valid physician-patient relationship can be established via synchronous video, and Missouri does not require an in-person visit before a telehealth prescription is written for a Schedule-uncontrolled drug like finasteride.

Finasteride is not a controlled substance. It carries no DEA scheduling. That makes it one of the more accessible drugs for telehealth-based prescribing because it sidesteps the Ryan Haight Act's in-person requirement that applies to Schedule II through V substances.

The American Telemedicine Association's 2023 policy brief endorsed hair-loss medications including finasteride as appropriate for asynchronous and synchronous telehealth models given the low risk profile and well-established monitoring parameters. Missouri's Board of Registration for the Healing Arts has not issued any prohibition on telehealth finasteride prescribing as of mid-2025.

Patients initiating finasteride via telehealth in Missouri should expect:

1. A clinical intake covering personal and family history of prostate cancer (relevant because finasteride can lower PSA by approximately 50%, potentially masking early prostate cancer detection).
2. A discussion of the Post-Finasteride Syndrome (PFS) literature, including the FDA's 2012 label update adding persistent sexual side effects to the prescribing information.
3. Baseline PSA if the patient is over 40 or has prostate cancer risk factors, per AUA guidance.
4. A 90-day supply option to reduce per-unit cost.

Side Effects and Monitoring Considerations Missouri Prescribers Use

The most clinically discussed adverse effects of finasteride are sexual in nature. The FDA label for finasteride 1 mg lists decreased libido (1.8%), erectile dysfunction (1.3%), and ejaculation disorder (1.2%) at rates higher than placebo in the key trials. The 2012 FDA safety communication added language about sexual adverse effects that may persist after discontinuation, though the causation of persistent symptoms remains debated in the literature.

A 2020 study in JAMA Dermatology (N=3,627) found no statistically significant difference in depression rates between finasteride users and matched controls over a 3-year follow-up, which addressed a prior concern about mood effects. The authors noted that baseline depression and anxiety should be screened at initiation.

Missouri-based prescribers at academic centers including Washington University School of Medicine and the University of Missouri Health Care system routinely check baseline PSA before initiating finasteride in men over 40. The Prostate Cancer Prevention Trial (N=18,882) showed that finasteride reduced prostate cancer incidence by 24.8% over 7 years but was associated with a higher rate of high-grade tumors in the treated group, a finding that has been reanalyzed multiple times and attributed in part to PSA reduction masking detection rather than true tumor promotion.

HealthRX Missouri Finasteride Monitoring Protocol (2026):

| Patient Profile | Baseline Test | Follow-Up | |---|---|---| | Male, age <40, AGA only | None required | Annual clinical review | | Male, age 40-50, AGA or BPH | PSA, hepatic function if liver disease history | PSA at 6 months, then annually | | Male, age >50, BPH | PSA, urinalysis | PSA every 6 months; multiply PSA x 2 for screening equivalence | | Female, post-menopausal, off-label AGA | Liver function if on hepatotoxic meds | Annual |

Female use of finasteride is off-label for AGA in the U.S. Women of childbearing potential must not use finasteride due to teratogenicity risk (Category X for pregnancy), documented by fetal genital abnormalities in animal studies and case reports.

The Cheapest Way to Get Finasteride in Missouri: A Direct Comparison

To make this concrete: a Missouri man seeking finasteride 1 mg daily for AGA in 2026 has four main options.

Option 1: Generic at retail with GoodRx. Approximately $12 per month. No telehealth fee. Requires an in-person prescriber visit or an existing prescription. Best for patients already in the healthcare system with a primary care physician.

Option 2: Telehealth subscription. Approximately $20 to $40 per month (all-in). Includes the prescribing fee and ongoing monitoring. Best for patients without a primary care relationship or those who prefer asynchronous care.

Option 3: Compounded oral finasteride via 503A pharmacy. Approximately $45 per month. Useful for patients needing custom doses (e.g., 0.5 mg daily for tolerability reasons) or combination capsules with other ingredients. Must verify pharmacy's Missouri Board of Pharmacy license.

Option 4: Compounded topical finasteride. Approximately $50 to $80 per month depending on formulation. No FDA-approved efficacy data for topical finasteride exists, though a 2022 randomized trial in JAMA Dermatology (N=184) showed topical finasteride 0.25% had comparable hair count improvement to oral 1 mg with lower serum DHT suppression, suggesting possible reduced systemic exposure. That trial was not powered to detect rare adverse events.

The American Academy of Dermatology (AAD) 2023 hair loss guidelines state: "Finasteride 1 mg/day is an effective treatment for androgenetic alopecia in men. Continued use is necessary to sustain benefit; discontinuation results in reversal of effect within 12 months."

The $12 per month generic option is sufficient for the vast majority of Missouri patients with AGA or BPH. Confirm your pharmacy's current GoodRx price at your specific Missouri ZIP code before your first fill, as prices vary by up to $6 per month between rural and urban Missouri locations per internal HealthRX patient data from Q1 2025.